146 related articles for article (PubMed ID: 29955125)
1. FHL3 links cell growth and self-renewal by modulating SOX4 in glioma.
Han W; Hu P; Wu F; Wang S; Hu Y; Li S; Jiang T; Qiang B; Peng X
Cell Death Differ; 2019 May; 26(5):796-811. PubMed ID: 29955125
[TBL] [Abstract][Full Text] [Related]
2. Glioma-initiating cells retain their tumorigenicity through integration of the Sox axis and Oct4 protein.
Ikushima H; Todo T; Ino Y; Takahashi M; Saito N; Miyazawa K; Miyazono K
J Biol Chem; 2011 Dec; 286(48):41434-41441. PubMed ID: 21987575
[TBL] [Abstract][Full Text] [Related]
3. Dual inhibition of Src and PLK1 regulate stemness and induce apoptosis through Notch1-SOX2 signaling in EGFRvIII positive glioma stem cells (GSCs).
Li X; Tao Z; Wang H; Deng Z; Zhou Y; Du Z
Exp Cell Res; 2020 Nov; 396(1):112261. PubMed ID: 32896567
[TBL] [Abstract][Full Text] [Related]
4. TGF-β1 secreted by M2 phenotype macrophages enhances the stemness and migration of glioma cells via the SMAD2/3 signalling pathway.
Liu Z; Kuang W; Zhou Q; Zhang Y
Int J Mol Med; 2018 Dec; 42(6):3395-3403. PubMed ID: 30320350
[TBL] [Abstract][Full Text] [Related]
5. PCBP2 promotes the development of glioma by regulating FHL3/TGF-β/Smad signaling pathway.
Mao J; Sun Z; Cui Y; Du N; Guo H; Wei J; Hao Z; Zheng L
J Cell Physiol; 2020 Apr; 235(4):3280-3291. PubMed ID: 31693182
[TBL] [Abstract][Full Text] [Related]
6. Activation of estrogen receptor beta signaling reduces stemness of glioma stem cells.
Sareddy GR; Pratap UP; Venkata PP; Zhou M; Alejo S; Viswanadhapalli S; Tekmal RR; Brenner AJ; Vadlamudi RK
Stem Cells; 2021 May; 39(5):536-550. PubMed ID: 33470499
[TBL] [Abstract][Full Text] [Related]
7. A new 2-pyrone derivative, 5-bromo-3-(3-hydroxyprop-1-ynyl)-2H-pyran-2-one, suppresses stemness in glioma stem-like cells.
Kim RK; Kim MJ; Yoon CH; Lim EJ; Yoo KC; Lee GH; Kim YH; Kim H; Jin YB; Lee YJ; Cho CG; Oh YS; Gye MC; Suh Y; Lee SJ
Mol Pharmacol; 2012 Sep; 82(3):400-7. PubMed ID: 22648970
[TBL] [Abstract][Full Text] [Related]
8. NFAT1-Mediated Regulation of NDEL1 Promotes Growth and Invasion of Glioma Stem-like Cells.
Jiang Y; Song Y; Wang R; Hu T; Zhang D; Wang Z; Tie X; Wang M; Han S
Cancer Res; 2019 May; 79(10):2593-2603. PubMed ID: 30940662
[TBL] [Abstract][Full Text] [Related]
9. Targeting the Notch-regulated non-coding RNA TUG1 for glioma treatment.
Katsushima K; Natsume A; Ohka F; Shinjo K; Hatanaka A; Ichimura N; Sato S; Takahashi S; Kimura H; Totoki Y; Shibata T; Naito M; Kim HJ; Miyata K; Kataoka K; Kondo Y
Nat Commun; 2016 Dec; 7():13616. PubMed ID: 27922002
[TBL] [Abstract][Full Text] [Related]
10. ER stress inducer tunicamycin suppresses the self-renewal of glioma-initiating cell partly through inhibiting Sox2 translation.
Xing Y; Ge Y; Liu C; Zhang X; Jiang J; Wei Y
Oncotarget; 2016 Jun; 7(24):36395-36406. PubMed ID: 27119230
[TBL] [Abstract][Full Text] [Related]
11. Tanshinone IIA inhibits the growth, attenuates the stemness and induces the apoptosis of human glioma stem cells.
Yang L; Guo H; Dong L; Wang L; Liu C; Wang X
Oncol Rep; 2014 Sep; 32(3):1303-11. PubMed ID: 24970314
[TBL] [Abstract][Full Text] [Related]
12. miR-92a-3p Exerts Various Effects in Glioma and Glioma Stem-Like Cells Specifically Targeting CDH1/β-Catenin and Notch-1/Akt Signaling Pathways.
Song H; Zhang Y; Liu N; Zhao S; Kong Y; Yuan L
Int J Mol Sci; 2016 Oct; 17(11):. PubMed ID: 27801803
[TBL] [Abstract][Full Text] [Related]
13. NSPc1 promotes cancer stem cell self-renewal by repressing the synthesis of all-trans retinoic acid via targeting RDH16 in malignant glioma.
Hu PS; Xia QS; Wu F; Li DK; Qi YJ; Hu Y; Wei ZZ; Li SS; Tian NY; Wei QF; Shen LJ; Yin B; Jiang T; Yuan JG; Qiang BQ; Han W; Peng XZ
Oncogene; 2017 Aug; 36(33):4706-4718. PubMed ID: 28394339
[TBL] [Abstract][Full Text] [Related]
14. ID4 imparts chemoresistance and cancer stemness to glioma cells by derepressing miR-9*-mediated suppression of SOX2.
Jeon HM; Sohn YW; Oh SY; Kim SH; Beck S; Kim S; Kim H
Cancer Res; 2011 May; 71(9):3410-21. PubMed ID: 21531766
[TBL] [Abstract][Full Text] [Related]
15. Autocrine TGF-beta signaling maintains tumorigenicity of glioma-initiating cells through Sry-related HMG-box factors.
Ikushima H; Todo T; Ino Y; Takahashi M; Miyazawa K; Miyazono K
Cell Stem Cell; 2009 Nov; 5(5):504-14. PubMed ID: 19896441
[TBL] [Abstract][Full Text] [Related]
16. Cytomegalovirus Immediate-Early Proteins Promote Stemness Properties in Glioblastoma.
Soroceanu L; Matlaf L; Khan S; Akhavan A; Singer E; Bezrookove V; Decker S; Ghanny S; Hadaczek P; Bengtsson H; Ohlfest J; Luciani-Torres MG; Harkins L; Perry A; Guo H; Soteropoulos P; Cobbs CS
Cancer Res; 2015 Aug; 75(15):3065-76. PubMed ID: 26239477
[TBL] [Abstract][Full Text] [Related]
17. Oct4A palmitoylation modulates tumorigenicity and stemness in human glioblastoma cells.
Chen X; Niu W; Fan X; Yang H; Zhao C; Fan J; Yao X; Fang Z
Neuro Oncol; 2023 Jan; 25(1):82-96. PubMed ID: 35727735
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of ID1-BMPR2 Intrinsic Signaling Sensitizes Glioma Stem Cells to Differentiation Therapy.
Jin X; Jin X; Kim LJY; Dixit D; Jeon HY; Kim EJ; Kim JK; Lee SY; Yin J; Rich JN; Kim H
Clin Cancer Res; 2018 Jan; 24(2):383-394. PubMed ID: 29208670
[No Abstract] [Full Text] [Related]
19. The LIM-only transcription factor LMO2 determines tumorigenic and angiogenic traits in glioma stem cells.
Kim SH; Kim EJ; Hitomi M; Oh SY; Jin X; Jeon HM; Beck S; Jin X; Kim JK; Park CG; Chang SY; Yin J; Kim T; Jeon YJ; Song J; Lim YC; Lathia JD; Nakano I; Kim H
Cell Death Differ; 2015 Sep; 22(9):1517-25. PubMed ID: 25721045
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of Cathepsin L promotes radiosensitivity of glioma stem cells both in vivo and in vitro.
Wang W; Long L; Wang L; Tan C; Fei X; Chen L; Huang Q; Liang Z
Cancer Lett; 2016 Feb; 371(2):274-84. PubMed ID: 26706414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
